Molecular Genetics Studies of Cancer Patients and Their Relatives
City of Hope Medical Center · with National Cancer Institute (NCI) · NCT04185935
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 999999
- US sites recruiting
- 34
- Study start
- April 18, 1997
- Record last updated
- June 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This trial studies the genetic and behavioral factors that may contribute to the development of specific cancers and how these factors may affect the outcome of the disease in patients with a history of cancer and their relatives.
Being studied: Biospecimen Collection; Questionnaire Administration
Conditions: Malignant Neoplasm
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Individuals must have a personal history of cancer and/or a family history of cancer suggestive of the presence of an inherited predisposition. This inherited predisposition might manifest as:
- Young age cancer diagnosis
- Multiple primary neoplasms in affected member
- The presence of rare tumor types in the family
- Congenital malformations
- Any other family clustering of cancer
- Any other cancer-predisposing genetic diseases/conditions
- Individuals may also be eligible by participation in the City of Hope Cancer Screening \& Prevention Program Network (CSPPN) clinical service or on the basis of membership in a group known or suspected to have an increased risk of carrying a genetic alteration or of sustaining a particular exposure that would place that at increased risk of cancer. (Examples would include members of occupational cohorts like asbestos workers, individuals with multiple dysplastic nevi in the absence of a family history of cancer, and individuals descended from a particular tribe in the American Southwest who have an increased incidence of a rare genetic alteration associated with an increased risk of a specific cancer.)
- Individuals and families may be referred to us in a number of different ways. After initial contact is made with a individual or family by family studies personnel; an individual within the bloodline will be identified as the historian. There may be more than one historian within a family
- At least one historian must be wiling to provide information or access as needed to contact appropriate family members for documentation of cancer and for consent. An individual is considered to be eligible to participate if they criteria; contact with relatives is not always indicated
- Individuals who are under 18 are eligible for study if they meet the criteria. Consent for participation must be given by a legal guardian or parent
- Deceased patients may be included in the study. Public records, such as death certificates, can be used to confirm information from individuals or family members. If medical records are needed, consent for these records will be obtained from the deceased's next of kin. Next of kin refers to the following hierarchy of relatives; spouse, offspring, parents, and siblings. (Any further use of next of kin in this protocol should relate back to this hierarchy.) Archived tissue samples, such as pathology blocks or snap frozen tumor from a pathology department tumor bank (discard specimens) may be used for genetic research
Exclusion Criteria
- A family may be ineligible for study if the historian will not allow access to anyone within the family and thus, the accuracy of the family history cannot be established
Recruiting US locations
Valleywise Comprehensive Health Center - Phoenix
Phoenix, AZ 85008
Site contact: Ian K. Komenaka · 602-344-5368 · Ian_Komenaka@dmgaz.org
John Muir Medical Center-Concord Campus
Concord, CA 94520
Site contact: Shellie Campos · 925-947-3322 · shellie.campos@johnmuirhealth.com
City of Hope Medical Center
Duarte, CA 91010
Site contact: Jeffrey N. Weitzel · 626-218-4334 · jweitzel@coh.org
Saint Jude Medical Center
Fullerton, CA 92835
Site contact: William E. Lawler · 714-446-5801 · William.Lawlor@StJoe.org
Saddleback Memorial Medical Center
Laguna Hills, CA 92653
Site contact: Jeffrey N. Weitzel · 626-218-4334 · jweitzel@coh.org
USC / Norris Comprehensive Cancer Center
Los Angeles, CA 90033
Site contact: Charite Ricker · 323-409-7710 · Charite.Ricker@med.usc.edu
Saint Joseph Hospital - Orange
Orange, CA 92868
Site contact: Jeffrey N. Weitzel · 626-218-4334 · jweitzel@coh.org
Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, CA 95661
Site contact: Kristie A. Bobolis · 916-782-5106 · bobolis@surewest.net
Cancer Center of Santa Barbara
Santa Barbara, CA 93105
Site contact: Frederic C. Kass · 805-563-5854 · fkass@ccsb.org
Lynn Regional Cancer Center - West
Boca Raton, FL 33428
Site contact: Louise E. Morrell · 561-955-2141 · LMorrell@brrh.com
Holy Cross Hospital
Fort Lauderdale, FL 33308
Site contact: Zdenka E. Segota · 954-267-7709 · Ena.segota@holy-cross.com
Kootenai Cancer Center
Post Falls, ID 83854
Site contact: Jeffrey W. Allen · 208-625-4728 · Mhander@kh.org
John H Stroger Jr Hospital of Cook County
Chicago, IL 60612
Site contact: Pamela Ganschow · 312-864-4436 · pganschow@cookcountyhhs.org
Rush University Medical Center
Chicago, IL 60612
Site contact: Lydia Usha · 312-563-2200 · Lydia_Usha@rush.edu
Mercy Hospital
Cedar Rapids, IA 52403
Site contact: Amie Hass · 319-398-6732 · ahass@mercycare.org
Suburban Hospital
Bethesda, MD 20814
Site contact: Carolyn B. Hendricks · 301-897-1503 · carolyn.hendricks53@verizon.net
Frederick Oncology Hematology Associates
Frederick, MD 21702
Site contact: Patricia A. Rice · 301-418-5010 · price@fmh.org
Steward Saint Elizabeth's Medical Center
Brighton, MA 02135
Site contact: Beth B. Herrick · 617-789-3232 · Beth.Herrick@steward.org
Hunterdon Medical Center
Flemington, NJ 08822
Site contact: Kenneth B. Blankstein · 908-788-2566 · kblankstein@hhpnj.org
Lovelace Medical Center-Downtown
Albuquerque, NM 87102
Site contact: Malcolm H. Purdy · 505-727-3040 · malcolm.purdy@ardenthealth.com
New Mexico Oncology Hematology Consultants
Albuquerque, NM 87109
Site contact: Annette C. Fontaine · 505-480-1462 · afontaine@nmohc.com
Presbyterian Kaseman Hospital
Albuquerque, NM 87110
Site contact: Kenneth J. Smith · 505-559-6143
Mount Kisco Medical Group at Northern Westchester Hospital
Mount Kisco, NY 10549-3417
Site contact: Nancy Cohen · 914-242-7649 · NCohen@nwhc.net
Health Quest Medical Practice PC-Cardio Thoracic
Poughkeepsie, NY 12601
Site contact: Jonathan Clyman · 845-483-6279 · jclyman@Health-quest.org
Aultman Health Foundation
Canton, OH 44710
Site contact: Shruti Trehan · 330-363-2286 · Shruti.trehan@aultman.com
Saint Charles Health System
Bend, OR 97701
Site contact: Coralia B. Calomeni · 541-706-5800 · cbcalomeni@stcharleshealthcare.org
Paoli Memorial Hospital
Paoli, PA 19301
Site contact: Michael B. Dabrow · DabrowM@MLHS.ORG
Reading Hospital
West Reading, PA 19611
Site contact: Terrence P. Cescon · 484-628-8000 · CesconT@readinghospital.org
The Don and Sybil Harrington Cancer Center
Amarillo, TX 79106
Site contact: Anita Ravipati · aravipati@harringtoncc.org
Doctor's Hospital of Laredo
Laredo, TX 78041
Site contact: Gary W. Unzeitig · 956-726-3691 · drgwu@laredobreastcare.com
Covenant Medical Center
Lubbock, TX 79410
Site contact: Isaac Tafur · 806-725-7993 · oncmd98@yahoo.com
Saint Agnes Hospital/Agnesian Cancer Center
Fond du Lac, WI 54935
Site contact: Michael W. Jones · 920-926-4100
ProHealth Waukesha Memorial Hospital
Waukesha, WI 53188
Site contact: Christopher R. Hake · 262-928-5539 · chakemd@gmail.com
Cheyenne Regional Medical Center-West
Cheyenne, WY 82001
Site contact: Jennifer Van Horn · 307-996-1517 · Jennifer.VanHorn@crmcwy.org
Study contacts (from the official record)
- Stephen Gruber · sgruber@coh.org
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55